Ironwood Pharmaceuticals Inc (IRWD)

Return on equity (ROE)

		Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net income	US$ in thousands	-1,002,240	175,065	528,448	106,176	21,505
Total stockholders’ equity	US$ in thousands	-346,295	652,378	605,911	62,640	-93,251
ROE		—	26.83%	87.22%	169.50%	—

December 31, 2023 calculation

ROE = Net income ÷ Total stockholders’ equity
= $-1,002,240K ÷ $-346,295K
= —

Ironwood Pharmaceuticals Inc's return on equity (ROE) has shown a declining trend over the years, based on the data provided. In 2022, the ROE was 26.83%, declining significantly from the previous year's ROE of 87.22% in 2021. Similarly, in 2021, there was a notable decrease from the high ROE of 169.50% in 2020.

The absence of ROE data for 2023 and 2019 makes it challenging to identify the specific reasons for the fluctuations in the ROE during those years. However, based on the available data, it is evident that the company's ROE has been volatile, indicating potential shifts in the company's profitability and ability to generate returns for its shareholders.

It is crucial for stakeholders to further investigate the company's financial performance, efficiency in asset utilization, and profitability drivers to better understand the factors impacting Ironwood Pharmaceuticals Inc's ROE dynamics over the years and to make informed investment decisions.